- Home
- BDX
as 04-18-2025 1:32pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 57.9B | IPO Year: | 1962 |
| Target Price: | $275.71 | AVG Volume (30 days): | 2.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.94 | EPS Growth: | 41.25 |
| 52 Week Low/High: | $193.03 - $251.99 | Next Earning Date: | 05-01-2025 |
| Revenue: | $20,640,000,000 | Revenue Growth: | 5.89% |
| Revenue Growth (this year): | 9.27% | Revenue Growth (next year): | 4.98% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Byrd Richard | BDX | EVP & President Interventional | Mar 18 '25 | Sell | $230.00 | 459 | $105,570.00 | 6,952 | |
| Byrd Richard | BDX | EVP & President Interventional | Mar 12 '25 | Sell | $224.91 | 1,940 | $436,325.40 | 6,952 | |
| SCOTT BERTRAM L | BDX | Director | Feb 12 '25 | Sell | $227.99 | 700 | $159,593.00 | 36,033 | |
| Henderson Jeffrey William | BDX | Director | Feb 10 '25 | Buy | $233.62 | 1,500 | $350,430.00 | 8,015 | |
| Neal Shana Carol | BDX | EVP and Chief People Officer | Jan 21 '25 | Sell | $240.00 | 787 | $188,880.00 | 15,414 | |
| Shan David | BDX | EVP and Chief ISC Officer | Jan 21 '25 | Sell | $240.00 | 500 | $120,000.00 | 5,741 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
Insider Monkey
3 days ago
Is Becton, Dickinson and Company (BDX) the Best Dividend Monarch to Invest in Now?
StockStory
9 days ago
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know
Zacks
11 days ago
BD Seeks Potential Buyers for Life Sciences Business Division
MT Newswires
12 days ago
Citigroup Adjusts Becton Dickinson and Co. Price Target to $270 From $275, Maintains Buy Rating
MT Newswires
12 days ago
Barclays Adjusts PT on Becton Dickinson and Co. to $261 From $279, Keeps Overweight Rating
Zacks
12 days ago
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Morningstar Research
14 days ago
Analyst Report: Becton, Dickinson and Company
Insider Monkey
15 days ago
Should You be Confident in Becton, Dickinson and Company’s (BDX) Ability to Deliver Long-Term Returns?
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.